Nekton Capital Ltd. Qiagen N.V. Transaction History

Nekton Capital Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$39.13 - $47.24 $43.8 Million - $52.8 Million	-1,118,457 Reduced 64.52%	614,940 $24.9 Million
Q2 2023 Aug 14, 2023	SELL	$43.93 - $46.76 $2.17 Million - $2.31 Million	-49,500 Reduced 2.78%	1,733,397 $78.1 Million
Q4 2022 Feb 14, 2023	BUY	$41.91 - $50.48 $522,450 - $629,283	12,466 Added 0.7%	1,782,897 $89.2 Million
Q3 2022 Nov 14, 2022	BUY	$40.9 - $50.42 $26.8 Million - $33.1 Million	656,304 Added 58.91%	1,770,431 $73.1 Million
Q1 2022 May 16, 2022	BUY	$42.23 - $54.3 $35.2 Million - $45.3 Million	834,591 Added 298.56%	1,114,127 $54.6 Million

Q4 2021 Feb 10, 2022	BUY	$50.62 - $56.47 $14.2 Million - $15.8 Million	279,536 New	279,536 $15.6 Million

6.76M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.16B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Nekton Capital Ltd., based on Form 13F filings with the SEC.

Stay updated on Nekton Capital Ltd. with notifications on news.